Forge Investment Outlook Q2 2024Road to Recovery: Private Market Accelerates in Q1
Forge Investment Outlook Q2 2024
Trading
Data
Solutions
Insights
About
Capital Rx is a health technology company built around the mission of changing the way prescription drugs are priced and patients are serviced. Its Clearinghouse Model® is the first ethical framework for drug pricing. Capital Rx's enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem in one platform. This company was founded in 2017 and is headquartered in New York, NY.
Capital Rx is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Capital Rx pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Capital Rx is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 3/28/2024 | Series E | $115MM raised | $XXX.XX | $XXX.XX |
| 8/10/2023 | Series D | $72MM raised | $XXX.XX | $XXX.XX |
| 6/13/2022 | Series C | $106MM raised | $XXX.XX | $XXX.XX |
| 2/2/2021 | Series B | $50MM raised | $XXX.XX | $XXX.XX |
| 7/19/2019 | Series A | $16.38MM raised | $XXX.XX | $XXX.XX |
| 3/1/2018 | Series Seed | $3MM raised | $XXX.XX | $XXX.XX |
